Dublin, July 11, 2022 (GLOBE NEWSWIRE) -- The "Global Hospital Care Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.
Global Hospital Care Partnering 2015 to 2022 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2015.
- Trends in Hospital Care partnering deals
- Financial deal terms for headline, upfront and royalty by stage of development
- Hospital Care partnering agreement structure
- Hospital Care partnering contract documents
- Top Hospital Care deals by value
- Most active Hospital Care dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Hospital Care Partnering 2015 to 2022 includes:
- Trends in Hospital Care dealmaking in the biopharma industry since 2015
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Hospital Care deal contract documents
- Comprehensive access to over 1200 Hospital Care deal records
- The leading Hospital Care deals by value since 2015
- Most active Hospital Care dealmakers since 2015
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Hospital Care dealmaking
2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication
Chapter 3 -Financial deal terms for Hospital Care partnering
3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates
Chapter 4 - Leading Hospital Care deals and dealmakers
4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value
Chapter 5 - Hospital Care contract document directory
5.1. Introduction
5.2. Hospital Care partnering deals where contract document available
Chapter 6 - Hospital Care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hospital Care therapeutic target
Companies Mentioned
- 3D-Side
- 3D Systems
- 3M
- 3SBio
- 4WEB Medical
- 7 Hills Pharma
- 7D Surgical
- 11 Health and Technologies
- 111
- A&E Medical
- AAP Implantate AG
- Aatru Medical
- Abbvie
- Abiomed
- Ab Medica
- Abram Scientific
- Absolute Antibody
- AbSorber
- Acacia Pharma
- Acacia Research
- Acare Medical Science
- Accelus
- Accenture
- Access Scientific
- Accord Healthcare
- Accuray
- AccuTec Blades
- Acelity
- Acell
- Acelrx Pharmaceuticals
- Acentrus Specialty
- Acerus
- ActLight
- Acuity Healthcare
- Acuna-Fombona
- AdaptHealth
- Adaptimmune
- ADAS 3D Medical
- Adeor Medical
- Adhezion Biomedical
- ADIENNE Pharma & Biotech
- Admedus
- Advanced Aesthetic Technologies
- Advanced Cooling Therapy
- Advanced Guidance Technologies
- Advanced IT Concepts
- Advanced Ultrasound Systems
- Advantage Medical
- Advanz Pharma
- AdventHealth
- Aerapy
- Aerobiotix
- Aesculap
- Aesthetic Management Partners
- Aesthetic Medical International
- Aethlon Medical
- Aetna
- Agadia Systems
- AgeX Therapeutics
- Agiliti
- AgNovos Healthcare
- Aguettant
- Aidoc
- Aiforia Technologies
- AirStrip Technologies
- AirXpanders
- Aitrics
- Akari Therapeutics
- Akers Biosciences
- Akumin
- ALASTIN Skincare
- Alfasigma
- Algeos
- AliMed
- AliveCor
- ALK-Abello
- Allegheny Technologies
- Allenex
- Allergan
- Allergan Aesthetics
- Alliance Medical
- Allied Centre for Medical Excellence
- Alliqua Biomedical
- Alloksys Life Sciences
- AlloSource
- Almirall
- Alnylam Pharmaceuticals
- Alpha Imaging
- Alphamedix
- Alphatec Spine
- Altan Pharma
- Altaris Capital Partners
- Altasciences
- Altitude International
- Alume Biosciences
- Alvarado Hospital Medical Center
- Alyzen Medical Physics
- Amag Pharmaceuticals
- Ambra Health
- Ambu
- Amedica
- Amedisys
- Amendia
- Amend Surgical
- American Academy of Orthopaedic Surgeons
- American College of Chest Physicians
- American Health Imaging
- American Medical Technologies
- American Society for Aesthetic Plastic Surgery
- American Well
- Amerinet
- AmerisourceBergen
- Amgen
- AMI
- Amicrobe
- AMNIOX
- Amomed Pharma
- Amplifire
- Amplyx Pharmaceuticals
- Ancestry
- Anelixis Therapeutics
- Anelto
- Angiodynamics
- Angion Biomedica
- Angsana Molecular & Diagnostics
- Anika Therapeutics
- Anita Tecnica
- ANP Technologies
- Antares Pharma
- Anthem
- Antibe Therapeutics
- Apex Physics Partners
- ApiFix
- Apollo Endosurgery
- Appalachian Regional Healthcare
- Apple
- Applied DNA Sciences
- Applimotion
- APR Medtech
- Aptevo Therapeutics
- Archer Capital
- Arch Therapeutics
- argenx
- Argon Medical Devices
- Aridea Solutions
- Aridis Pharmaceuticals
- Arjo
- Arkansas Childrens Hospital
- Armaghan Salamat Kish
- Armis Biopharma
- Armor
- Arsenal Medical
- Artegraft
- Arteriocyte Medical Systems
- Arthrex
- Arthrosurface
- ARxIUM
- Asahi Kasei
- Ascendum
- Ascension
- Ascension Saint Thomas
- Asensus Surgical
- ASICO
- AskAt
- Asklepios Group
- Aspen Surgical Products
- Assure
- Astarte Medical
- Astellas Pharma
- AstraZeneca
- Asys
- Athersys
- Atlas Lift Tech
- ATL Technology
- Atnahs Pharma
- Atos Medical
- Atricure
For more information about this report visit https://www.researchandmarkets.com/r/4e90g0
